These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 26356760)

  • 1. Connectivity mapping using a combined gene signature from multiple colorectal cancer datasets identified candidate drugs including existing chemotherapies.
    Wen Q; O'Reilly P; Dunne PD; Lawler M; Van Schaeybroeck S; Salto-Tellez M; Hamilton P; Zhang SD
    BMC Syst Biol; 2015; 9 Suppl 5(Suppl 5):S4. PubMed ID: 26356760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KRAS mutant colorectal cancer gene signatures identified angiotensin II receptor blockers as potential therapies.
    Wen Q; Dunne PD; O'Reilly PG; Li G; Bjourson AJ; McArt DG; Hamilton PW; Zhang SD
    Oncotarget; 2017 Jan; 8(2):3206-3225. PubMed ID: 27965461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A gene-signature progression approach to identifying candidate small-molecule cancer therapeutics with connectivity mapping.
    Wen Q; Kim CS; Hamilton PW; Zhang SD
    BMC Bioinformatics; 2016 May; 17(1):211. PubMed ID: 27170106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of genetic variants and gene network for drug repurposing in colorectal cancer.
    Irham LM; Wong HS; Chou WH; Adikusuma W; Mugiyanto E; Huang WC; Chang WC
    Pharmacol Res; 2020 Nov; 161():105203. PubMed ID: 32950641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An integrated meta-analysis approach to identifying medications with potential to alter breast cancer risk through connectivity mapping.
    Thillaiyampalam G; Liberante F; Murray L; Cardwell C; Mills K; Zhang SD
    BMC Bioinformatics; 2017 Dec; 18(1):581. PubMed ID: 29268695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptomic Data Mining and Repurposing for Computational Drug Discovery.
    Wang Y; Yella J; Jegga AG
    Methods Mol Biol; 2019; 1903():73-95. PubMed ID: 30547437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of candidate small-molecule therapeutics to cancer by gene-signature perturbation in connectivity mapping.
    McArt DG; Zhang SD
    PLoS One; 2011 Jan; 6(1):e16382. PubMed ID: 21305029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
    Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
    Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug discovery using clinical outcome-based Connectivity Mapping: application to ovarian cancer.
    Raghavan R; Hyter S; Pathak HB; Godwin AK; Konecny G; Wang C; Goode EL; Fridley BL
    BMC Genomics; 2016 Oct; 17(1):811. PubMed ID: 27756228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer in silico drug discovery: a systems biology tool for identifying candidate drugs to target specific molecular tumor subtypes.
    San Lucas FA; Fowler J; Chang K; Kopetz S; Vilar E; Scheet P
    Mol Cancer Ther; 2014 Dec; 13(12):3230-40. PubMed ID: 25349306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis.
    Rahman MR; Islam T; Gov E; Turanli B; Gulfidan G; Shahjaman M; Banu NA; Mollah MNH; Arga KY; Moni MA
    Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cudaMap: a GPU accelerated program for gene expression connectivity mapping.
    McArt DG; Bankhead P; Dunne PD; Salto-Tellez M; Hamilton P; Zhang SD
    BMC Bioinformatics; 2013 Oct; 14():305. PubMed ID: 24112435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A network-based predictive gene-expression signature for adjuvant chemotherapy benefit in stage II colorectal cancer.
    Cao B; Luo L; Feng L; Ma S; Chen T; Ren Y; Zha X; Cheng S; Zhang K; Chen C
    BMC Cancer; 2017 Dec; 17(1):844. PubMed ID: 29237416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cliques for the identification of gene signatures for colorectal cancer across population.
    Pradhan MP; Nagulapalli K; Palakal MJ
    BMC Syst Biol; 2012; 6 Suppl 3(Suppl 3):S17. PubMed ID: 23282040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNK2 as a key drug target for the treatment of metastatic colorectal cancer.
    Qi L; Ding Y
    Int J Biol Macromol; 2018 Nov; 119():48-52. PubMed ID: 30036625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional Module Connectivity Map (FMCM): a framework for searching repurposed drug compounds for systems treatment of cancer and an application to colorectal adenocarcinoma.
    Chung FH; Chiang YR; Tseng AL; Sung YC; Lu J; Huang MC; Ma N; Lee HC
    PLoS One; 2014; 9(1):e86299. PubMed ID: 24475102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities.
    Di J; Zheng B; Kong Q; Jiang Y; Liu S; Yang Y; Han X; Sheng Y; Zhang Y; Cheng L; Han J
    Mol Oncol; 2019 Oct; 13(10):2259-2277. PubMed ID: 31408580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potential drugs for diffuse large b-cell lymphoma based on bioinformatics and Connectivity Map database.
    Luo B; Gu YY; Wang XD; Chen G; Peng ZG
    Pathol Res Pract; 2018 Nov; 214(11):1854-1867. PubMed ID: 30244948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of natural products in colorectal cancer drug discovery.
    Miura K; Satoh M; Kinouchi M; Yamamoto K; Hasegawa Y; Kakugawa Y; Kawai M; Uchimi K; Aizawa H; Ohnuma S; Kajiwara T; Sakurai H; Fujiya T
    Expert Opin Drug Discov; 2015 Apr; 10(4):411-26. PubMed ID: 25724579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular biology in clinical cancer research: the example of digestive cancers].
    Lièvre A; Laurent-Puig P
    Rev Epidemiol Sante Publique; 2005 Jun; 53(3):267-82. PubMed ID: 16227914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.